Comments
FDA advisory panel backs J&J diabetes drug approval
11.01.2013. | (Reuters) - A panel of advisers to the U.S. Food and Drug Administration recommended the agency approve an experimental new treatment for diabetes developed by Johnson & Johnson, potentially making it the first drug of its type to be approved in the United States....
